Galderma Group AGGalderma Group AGGalderma Group AG

Galderma Group AG

No trades
No trades

Compare with Galderma Group AG


Market capitalization
‪36.25 B‬CHF
2.90CHF
‪509.09 M‬CHF
‪4.32 B‬CHF
‪184.52 M‬
Beta (1Y)
0.43
Next report date
Report period
EPS estimate
Revenue estimate
Employees (FY)
‪7.68 K‬
Revenue / Employee (1Y)
‪563.36 K‬CHF
Net income / Employee (1Y)
‪66.32 K‬CHF

Company info


CEO
Flemming Ørnskov
Headquarters
Zug
Founded
1981
IPO date
Mar 22, 2024
ISIN
CH1335392721
FIGI
BBG01LYFLBQ5
Identifiers
ISIN CH1335392721
CFI code
ESVUFR
Galderma Group AG engages in the provision of science-based premium dermatology solutions. The firm is also involved in delivering a synergistic portfolio of flagship brands spanning the full spectrum of the fast-growing self-care dermatology market. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Maturity dateMar 17, 2031
Coupon3.38% (Fixed)
Maturity dateMar 20, 2030
Coupon3.50% (Fixed)
Maturity dateMar 18, 2033
Coupon1.81% (Fixed)
Maturity dateSep 27, 2032
Coupon1.90% (Fixed)
Maturity dateDec 10, 2030
Coupon0.94% (Fixed)
Maturity dateMar 20, 2029
Coupon1.40% (Fixed)
Maturity dateSep 27, 2028
Coupon1.60% (Fixed)

See all GALD bonds 

Weight0.09%
Market value‪592.35 M‬
Weight0.12%
Market value‪394.77 M‬
Weight0.14%
Market value‪264.32 M‬
Weight10.88%
Market value‪242.95 M‬
Weight10.71%
Market value‪155.53 M‬
Weight0.16%
Market value‪124.41 M‬
Weight1.59%
Market value‪112.75 M‬
Weight0.25%
Market value‪96.17 M‬
Weight0.10%
Market value‪95.79 M‬
Weight0.12%
Market value‪81.19 M‬

Explore more ETFs 

Frequently asked questions


The current price of GALD is 153.70 CHF — it has increased by 0.84% in the past 24 hours. Watch Galderma Group AG stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange Galderma Group AG stocks are traded under the ticker GALD.
GALD stock has fallen by −5.29% compared to the previous week, the month change is a −10.73% fall, over the last year Galderma Group AG has showed a 3.99% increase.
We've gathered analysts' opinions on Galderma Group AG future price: according to them, GALD price has a max estimate of 260.38 CHF and a min estimate of 173.10 CHF. Watch GALD chart and read a more detailed Galderma Group AG stock forecast: see what analysts think of Galderma Group AG and suggest that you do with its stocks.
GALD reached its all-time high on Jun 30, 2026 with the price of 188.25 CHF, and its all-time low was 60.00 CHF and was reached on Mar 22, 2024. View more price dynamics on GALD chart.
See other stocks reaching their highest and lowest prices.
GALD stock is 3.12% volatile and has beta coefficient of 0.43. Track Galderma Group AG stock price on the chart and check out the list of the most volatile stocks — is Galderma Group AG there?
Today Galderma Group AG has the market capitalization of ‪36.25 B‬, it has decreased by −2.92% over the last week.
Yes, you can track Galderma Group AG financials in yearly and quarterly reports right on TradingView.
Galderma Group AG is going to release the next earnings report on Mar 11, 2027. Keep track of upcoming events with our Earnings Calendar.
GALD earnings for the last half-year are 1.89 CHF per share, whereas the estimation was 1.82 CHF, resulting in a 4.00% surprise. The estimated earnings for the next half-year are 2.03 CHF per share. See more details about Galderma Group AG earnings.
Galderma Group AG revenue for the last half-year amounts to ‪2.53 B‬ CHF, despite the estimated figure of ‪2.46 B‬ CHF. In the next half-year revenue is expected to reach ‪2.65 B‬ CHF.
GALD net income for the last half-year is ‪349.37 M‬ CHF, while the previous report showed ‪335.10 M‬ CHF of net income which accounts for 0.00% change. Track more Galderma Group AG financial stats to get the full picture.
Galderma Group AG dividend yield was 0.22% in 2025, and payout ratio reached 16.21%. The year before the numbers were 0.15% and 17.51% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 11, 2026, the company has ‪7.68 K‬ employees. See our rating of the largest employees — is Galderma Group AG on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Galderma Group AG EBITDA is ‪1.13 B‬ CHF, and current EBITDA margin is 22.43%. See more stats in Galderma Group AG financial statements.
Like other stocks, GALD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Galderma Group AG stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Galderma Group AG technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Galderma Group AG stock shows the neutral signal. See more of Galderma Group AG technicals for a more comprehensive analysis.